Skip to main content
CivicGate

SB 136 IN

Disclosures related to prescription drugs.

IN · session 2025 · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 8, 2025

Latest action (Jan 8, 2025) Authored by Senator Bohacek

Summary

Beginning January 1, 2026, requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide to a covered individual the national average drug acquisition cost of a generic drug on the written materials provided at the point of sale. Provides that if an agreement between a health plan and a pharmacy benefit manager that is entered into or renewed after December 31, 2025, provides that less than 85% of the estimated rebates will be deducted from the cost of prescription drugs before a covered individual's cost sharing requirement is determined, the pharmacy benefit manager must provide the policyholder with a notice on an annual basis that includes: (1) an explanation of what a rebate is; (2) an explanation of how rebates accrue to the health plan from the manufacturer; and (3) the aggregate amount of rebates that accrued to the health plan for prescription drugs dispensed under the policyholder's health plan for the previous year.

Sponsor (1)

Action history (2)

  1. Jan 8, 2025 First reading: referred to Committee on Health and Provider Services · upper
  2. Jan 8, 2025 Authored by Senator Bohacek · upper
Subjects
HEALTH; Prescription Drugs and MedicationsINSURANCE; Health InsuranceSTATE GOVERNMENT; Employees

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →